These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8950499)

  • 1. The pharmacology and effectiveness of specific lipid-active drugs: estrogen/sex steroids.
    LaRosa JC
    Coron Artery Dis; 1996 Sep; 7(9):683-8. PubMed ID: 8950499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased coronary events, HERS, and HRT: any connection?
    Rebar RW; Archer D
    Arch Intern Med; 2001 May; 161(10):1350-1. PubMed ID: 11371266
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestins and androgens.
    Whitehead M
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):161S-167S. PubMed ID: 7958012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.
    Johnson KC; Aragaki AK; Jackson R; Reiner A; Sandset PM; Rosing J; Dahm AE; Rosendaal F; Manson JE; Martin LW; Liu S; Kuller LH; Cushman M; Rossouw JE
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):418-24. PubMed ID: 26681757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
    Ellis J
    Clin Ther; 1986; 8(6):607-18. PubMed ID: 3539347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.
    Crook D; Cust MP; Gangar KF; Worthington M; Hillard TC; Stevenson JC; Whitehead MI; Wynn V
    Am J Obstet Gynecol; 1992 Mar; 166(3):950-5. PubMed ID: 1550171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
    Burkman RT
    Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of estrogens and progestins.
    LaRosa JC
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):140S-146S. PubMed ID: 7958008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
    JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen therapies, lipids, and the heart disease prevention controversy.
    Knopp RH; Aikawa K; Knopp EA
    Curr Cardiol Rep; 2003 Nov; 5(6):477-82. PubMed ID: 14558990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.